Carbidopa 4'-Phosphate manufacturers
- Foscarbidopa
-
- $1650.00
-
2026-05-11
- CAS:1907685-81-7
- Purity: 97.27%
- Supply Ability: 10g
- Foscarbidopa
-
-
2025-09-12
- CAS:1907685-81-7
- Min. Order: 1G
- Purity: 98%HPLC
- Supply Ability: 20tons
|
| | Carbidopa 4'-Phosphate Basic information |
| Product Name: | Carbidopa 4'-Phosphate | | Synonyms: | Carbidopa 4'-Phosphate;Carbidopa 4′-monophosphate;Benzenepropanoic acid, α-hydrazinyl-3-hydroxy-α-methyl-4-(phosphonooxy)-, (αS)-;Bedaquiline Impurity 43;(αS)-α-Hydrazinyl-3-hydroxy-α-methyl-4-(phosphonooxy)benzenepropanoic acid;Foscarbidopa;(αS)-α-Hydrazinyl-3-hydroxy-α-methyl-4-(phosphonooxy)benzenepropanoic acid (ACI) | | CAS: | 1907685-81-7 | | MF: | C10H15N2O7P | | MW: | 306.21 | | EINECS: | | | Product Categories: | | | Mol File: | 1907685-81-7.mol |  |
| | Carbidopa 4'-Phosphate Chemical Properties |
| Boiling point | 646.1±65.0 °C(Predicted) | | density | 1.632±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 1.20±0.50(Predicted) | | form | Solid | | color | White to off-white | | InChI | InChI=1/C10H15N2O7P/c1-10(12-11,9(14)15)5-6-2-3-8(7(13)4-6)19-20(16,17)18/h2-4,12-13H,5,11H2,1H3,(H,14,15)(H2,16,17,18)/t10-/s3 | | InChIKey | PQUZXFMHVSMUNG-JQHDBZEONA-N | | SMILES | C(O)(=O)[C@](NN)(C)CC1=CC=C(OP(O)(O)=O)C(O)=C1 |&1:3,r| |
| | Carbidopa 4'-Phosphate Usage And Synthesis |
| Uses | Foscarbidopa (ABBV-951; Carbidopa 4′-monophosphate) is a proagent of Carbidopa, acts as a dopamine receptor agonist[1][2]. | | Definition | ChEBI: Foscarbidopa is an L-tyrosine derivative that is carbidopa in which the hydroxy group at position 4' is replaced by a phosphonooxy group. It is a water-soluble prodrug of carbidopa which is used for the treatment of Parkinson's disease. It has a role as a prodrug and an antiparkinson drug. It is an O-phosphoamino acid, a L-tyrosine derivative and a non-proteinogenic L-alpha-amino acid. It is functionally related to a carbidopa (anhydrous). | | References | [1] Benoit CARDINAL-DAVID, et al. Carbidopa and L-Dopa Prodrugs and Methods of Use. US 20160106765 A1.
[2] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 32, No. 4, 2018. |
| | Carbidopa 4'-Phosphate Preparation Products And Raw materials |
|